New study shows potential improvement for Parkinson's treatment

A study by Sinopia Biosciences suggests that a new small molecule could enhance the effectiveness and reduce side effects of levodopa, the standard medication for Parkinson's disease.

We have not fully decoded this article yet, so read the full story at Times of San Diego.